Their PEG-PH20 program for pancreatic cancer seems very interesting to me. I had thought they may have results relatively quickly given the nature of the disease, though the company doesn't list any 2012 milestones for the program and clinicaltrials.gov has listed the end of 2013 (I've noticed those times tend to be worst case estimates).
Market Data 
Markets 
AI
